P3.02b-096 Osimertinib (AZD9291) in Asia-Pacific Patients with T790M Mutation-Positive Advanced NSCLC: Open-Label Phase II Study Results: Topic: EGFR RES
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology January 2017 12(1) Supplement:S1250-S1250 - Subject
- Language
- ISSN
- 1556-0864